Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: top (303), greatest (36), paramount (8)

Ruxolitinib

Description: Chemotherapy Protocol Myelofibrosis Ruxolitinib Regimen • Myelofibrosis – Ruxolitinib Indication • Ruxolitinib is recommen
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myelofibrosis/Ruxolitinib.pdf

Capecitabine-Epirubicin-Oxaliplatin (EOX)

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CAPECITABINE, EPIRUBICIN and OXALIPLATIN (EOX) Regimen • Gastrointestinal Cancer (upper) – C
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Capecitabine-Epirubicin-Oxaliplatin.pdf

Capecitabine-Cisplatin-Epirubicin (ECX)

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CAPECITABINE, CISPLATIN and EPIRUBICIN (ECX) Regimen • Gastrointestinal Cancer (upper) – Cap
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Capecitabine-Cisplatin-Epirubicin.pdf

Capecitabine 1250 (14)

Description: Chemotherapy Protocol BREAST CANCER CAPECITABINE 1250 (14 day) Regimen • Breast Cancer – Capecitabine 1250 (14 day) Indication • Treatment of loca
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Capecitabine1250-14.pdf

Capecitabine 1000 (14)

Description: Chemotherapy Protocol BREAST CANCER CAPECITABINE 1000 (14 day) Regimen • Breast Cancer – Capecitabine 1000 (14 day) Indication • Treatment of loca
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Capecitabine1000-14.pdf

Risk-reducing bilateral salpingo-oophorectomy (RRBSO) - patient information

Description: This factsheet explains what a risk-reducing bilateral salpingo-oophorectomy (RRBSO) is, what the procedure involves, and what the potential advantages
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Risk-reducing-bilateral-salpingo-oophorectomy-RRBSO-3080-PIL.pdf

'Cut and drop' removal of a percutaneous endoscopic gastrostomy (PEG) tube - patient information

Description: This factsheet explains why your child needs to have their percutaneous endoscopic gastrostomy (PEG) tube removed, what the procedure involves and
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Cut-and-drop-removal-of-a-percutaneous-endoscopic-gastrostomy-PEG-tube-3038-PIL.pdf

Exemestane-Palbociclib

Description: Chemotherapy Protocol Breast Cancer Exemestane-Palbociclib Regimen • Breast Cancer – Exemestane-Palbociclib Indication • Palbociclib in combination with a
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Exemestane-Palbociclib.pdf

Capecitabine-Lapatinib

Description: Chemotherapy Protocol BREAST CANCER CAPECITABINE-LAPATINIB This protocol may require funding Regimen • Breast Cancer – Capecitabine-Lapatinib Indi
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CapecitabineLapatinib.pdf

Mental wellbeing support on the neonatal intensive care unit (NICU) - patient information

Description: Patient information factsheet Mental wellbeing support on the neonatal intensive care unit (NICU) If your baby is unw
Url: /Media/UHS-website-2019/Patientinformation/Neonatal/Mental-wellbeing-support-on-the-neonatal-intensive-care-unit-NICU-2291-PIL.pdf

521 to 530 of 641

Previous … 51 52 53 54 55 … Next